describ
three
critic
ill
patient
coronaviru
diseas
wuhan
china
featur
profound
inflamm
treat
blood
purif
therapi
includ
plasma
exchang
adsorpt
potenti
effect
manag
cytokin
storm
pathogen
antibodi
shown
ad
limit
therapeut
option
patient
effort
propos
prove
benefit
ongo
outbreak
patient
need
icu
admiss
even
mechan
ventil
due
sever
respiratori
failur
mortal
increas
nonsurvivor
profound
hypoxia
inflammatori
respons
like
develop
acut
respiratori
distress
syndrom
ard
multipl
organ
dysfunct
syndrom
addit
reduc
peripher
lymphocyt
high
level
creactiv
protein
crp
significantli
abnorm
coagul
paramet
hallmark
sever
case
emerg
evid
indic
potenti
benefit
manag
cytokin
storm
via
use
steroid
block
antibodi
capabl
blood
purif
therapi
remov
pathogen
antibodi
cytokin
proven
multipl
scenario
patient
first
case
man
without
remark
past
medic
histori
felt
fever
lethargi
jan
diagnos
posit
igmigg
antibodi
bilater
ground
glass
shadow
chest
comput
tomographi
ct
one
week
later
treat
antibiot
ribavirin
fever
persist
aggrav
dyspnea
develop
februari
endotrach
intub
perform
sever
respiratori
failur
februari
transfer
icu
ventil
pressur
control
pc
mode
fraction
inspir
oxygen
posit
endexpiratori
pressur
peep
lab
test
show
persist
leukopenia
l
elev
inflamm
crp
mgl
refer
mgl
pgml
refer
pg
ml
treat
antibiot
gamma
globulin
support
therapi
observ
continu
decreas
platelet
count
minimum
valu
l
march
increas
ddimer
maximum
valu
march
inflammatori
marker
maximum
crp
mgl
pgml
march
prothrombin
time
pt
remain
stabl
march
dri
gangren
appear
right
index
finger
within
one
week
confirm
multipl
cerebr
infarct
brain
ct
bilater
jugular
venou
thrombi
doppler
ultrasound
march
antiphospholipid
antibodi
posit
glycoproteini
refer
anticardiolipin
acligg
refer
antiphospholipid
syndrom
ap
diagnos
treat
low
molecular
weight
heparin
aspirin
march
perform
three
session
plasma
exchang
dramat
reduct
titer
antiphospholipid
antibodi
inflammatori
marker
observ
acligg
crp
mgl
pgml
fig
march
patient
success
wean
ventil
remain
clinic
stabl
till
second
case
man
hypertens
present
fever
dyspnea
diarrhea
jan
one
week
later
diagnos
revers
realtim
transcriptas
polymeras
chain
reaction
hospit
worsen
dyspnea
feb
lab
test
show
leukopenia
l
elev
inflammatori
marker
crp
mgl
pgml
treat
antibiot
arbidol
methylprednisolon
oxygen
therapi
feb
respiratori
failur
requir
endotrach
intub
mechan
ventil
pc
mode
pc
peep
fio
refractori
respiratori
acidosi
hypoxia
abg
ph
co
mmhg
led
venousven
extra
corpor
membran
oxygen
vvecmo
therapi
meanwhil
treat
antibiot
gamma
globulin
hydrocortison
support
therapi
leukopenia
inflammatori
marker
elev
persist
lymphocyt
l
crp
mgl
pg
ml
feb
experienc
sudden
death
success
resuscit
continu
renal
replac
therapi
crrt
initi
perform
hemofilt
baxter
meyzieu
franc
modifi
surfac
treat
membran
adsorpt
capac
hemofilt
chang
everi
h
day
lab
test
improv
lymphocyt
l
crp
mgl
pgml
fig
avail
onlin
april
elsevi
inc
right
reserv
coagul
dic
right
lung
pneumothorax
march
anoth
sudden
death
resuscit
success
third
case
man
without
underli
diseas
admit
local
hospit
feb
report
fever
fatigu
one
week
diagnosi
confirm
posit
igmigg
antibodi
chest
ct
first
treat
lopinavir
ritonavir
transfer
icu
due
respiratori
failur
feb
given
endotrach
intub
mechan
ventil
pc
mode
pc
peep
fio
lab
test
show
leukopenia
l
inflamm
crp
mgl
pgml
treat
antibiot
gamma
globulin
support
therapi
leukopenia
persist
inflamm
intensifi
crp
mgl
pgml
feb
gave
methylprednisolon
crrt
hemofilt
feb
feb
stop
crrt
inflammatori
marker
almost
normal
two
day
crp
mgl
pgml
fig
ventil
set
quickli
downregul
wean
success
march
transfer
icu
rehabilit
march
knowledg
critic
ill
late
phase
quit
limit
case
highlight
presenc
cytokin
storm
pathogen
antibodi
three
week
onset
fig
correl
diseas
sever
monitor
inflamm
antibodi
import
especi
patient
infect
viru
persist
fever
abnorm
coagulopathi
expediti
control
cytokin
storm
earli
phase
might
benefici
select
patient
blood
purif
therapi
effect
limit
experi
therapi
toler
patient
perform
assist
nephrolog
specialist
order
minim
risk
infect
bleed
although
random
trial
data
lack
propos
multidisciplinari
effort
made
maxim
avail
blood
purif
therapi
proper
patient
work
support
nation
natur
scienc
foundat
china
grant
yq
yzz
author
declar
compet
interest
